Crohn’s disease: towards improving postsurgical outcomes

Med J Aust. 2013 Oct 21;199(8):524. doi: 10.5694/mja13.11186.
No abstract available

MeSH terms

  • Adalimumab
  • Adult
  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Biopsy
  • Child
  • Colonoscopy
  • Crohn Disease / microbiology
  • Crohn Disease / pathology
  • Crohn Disease / surgery*
  • Humans
  • Intestinal Mucosa / microbiology
  • Intestinal Mucosa / pathology
  • Outcome Assessment, Health Care*
  • Postoperative Care
  • Postoperative Complications / microbiology
  • Postoperative Complications / pathology
  • Postoperative Complications / prevention & control*
  • Reoperation
  • Risk Factors
  • Secondary Prevention
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal, Humanized
  • Tumor Necrosis Factor-alpha
  • Adalimumab